Who
Epidemiology · 2009
A researcher in the Science corpus: 1 paper; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Epidemiology — 5 citations into it
Whom Who trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Who overall
Papers from Who's perspective
Ordered by how strongly the researchers Who trusts endorse each paper. Same corpus, a different order for every researcher.
- Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. (New England Journal of Medicine)
- Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. (New England Journal of Medicine)
- High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up (British Journal of Cancer)
- Epidemiologic classification of human papillomavirus types associated with cervical cancer. (New England Journal of Medicine)
- The causal relation between human papillomavirus and cervical cancer. (Journal of Clinical Pathology)
- Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial. (The Lancet)
- HPV screening for cervical cancer in rural India. (New England Journal of Medicine)
- Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases. (Vaccine)
- Nonparametric Estimation from Incomplete Observations
- iArc monogrAphs on the evAluAtion oF cArcinogenic risks to humAns
Their papers
- Human papillomavirus vaccines: WHO position paper. (2009) — 998 citations